J Cramer

Summary

Affiliation: Yale University
Country: USA

Publications

  1. ncbi Tolerability of levetiracetam in elderly patients with CNS disorders
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, 950 Campbell Avenue G7E, Room 7 127, West Haven, CT 06516 2770, USA
    Epilepsy Res 56:135-45. 2003
  2. doi Tolerability of antiepileptic drugs: can we determine differences?
    Joyce A Cramer
    Yale University School of Medicine, USA
    Epilepsy Behav 23:187-92. 2012
  3. pmc Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system
    Anne C Vancott
    VA Pittsburgh Healthcare System, Neurology Division, Pittsburgh, PA, USA
    BMC Med 8:4. 2010
  4. ncbi Assessing the severity of seizures and epilepsy: which scales are valid?
    J A Cramer
    Departments of Neurology and Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
    Curr Opin Neurol 14:225-9. 2001
  5. pmc Effect of partial compliance on cardiovascular medication effectiveness
    Joyce A Cramer
    Yale University School of Medicine, 950 Campbell Avenue G7E, West Haven, CT 06516 2770, USA
    Heart 88:203-6. 2002
  6. ncbi Methodological considerations in using claims databases to evaluate persistence with bisphosphonates for osteoporosis
    Joyce A Cramer
    Department of Psychiatry, Yale UniversitySchool of Medicine, 950 Campbell Avenue 151D, West Haven, CT 06516 2770, USA
    Curr Med Res Opin 23:2369-77. 2007
  7. ncbi The impact of seizures and adverse effects on global health ratings
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    Epilepsy Behav 11:179-84. 2007
  8. ncbi Differentiating anxiety and depression symptoms in patients with partial epilepsy
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06516 2770, USA
    Epilepsy Behav 6:563-9. 2005
  9. ncbi The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    Epilepsy Behav 5:337-42. 2004
  10. ncbi Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes
    Joyce Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    Value Health 6:566-73. 2003

Detail Information

Publications66

  1. ncbi Tolerability of levetiracetam in elderly patients with CNS disorders
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, 950 Campbell Avenue G7E, Room 7 127, West Haven, CT 06516 2770, USA
    Epilepsy Res 56:135-45. 2003
    ..Overall, LEV was well tolerated by all patient groups. The favorable adverse event profile suggests that LEV might be suitable for use by elderly patients...
  2. doi Tolerability of antiepileptic drugs: can we determine differences?
    Joyce A Cramer
    Yale University School of Medicine, USA
    Epilepsy Behav 23:187-92. 2012
    ..A system of questioning every patient at every visit to elicit information may be helpful when balancing benefit-to-risk ratio of individualized therapy during everyday practice...
  3. pmc Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system
    Anne C Vancott
    VA Pittsburgh Healthcare System, Neurology Division, Pittsburgh, PA, USA
    BMC Med 8:4. 2010
    ..We examined the relationship between suicide-related behaviors and different AEDs in older veterans receiving new AED monotherapy from the Veterans Health Administration (VA), controlling for potential confounders...
  4. ncbi Assessing the severity of seizures and epilepsy: which scales are valid?
    J A Cramer
    Departments of Neurology and Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
    Curr Opin Neurol 14:225-9. 2001
    ..However, the disadvantages of each scale outweigh its usefulness. New approaches are needed to assess seizure severity for individuals and for use as an outcome measure after intervention such as surgery or medication changes...
  5. pmc Effect of partial compliance on cardiovascular medication effectiveness
    Joyce A Cramer
    Yale University School of Medicine, 950 Campbell Avenue G7E, West Haven, CT 06516 2770, USA
    Heart 88:203-6. 2002
  6. ncbi Methodological considerations in using claims databases to evaluate persistence with bisphosphonates for osteoporosis
    Joyce A Cramer
    Department of Psychiatry, Yale UniversitySchool of Medicine, 950 Campbell Avenue 151D, West Haven, CT 06516 2770, USA
    Curr Med Res Opin 23:2369-77. 2007
    ..Bisphosphonates (BPs) are used as an example because of the availability of diverse dosing options that can create a unique set of challenges for persistence analyses...
  7. ncbi The impact of seizures and adverse effects on global health ratings
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    Epilepsy Behav 11:179-84. 2007
    ..These data provide insight into the risk-benefit concerns of patients at equipoise when addressing the efficacy and AEs of AEDs...
  8. ncbi Differentiating anxiety and depression symptoms in patients with partial epilepsy
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06516 2770, USA
    Epilepsy Behav 6:563-9. 2005
    ..337 (anxiety) and 0.511 (depression)). The data suggest that patients may benefit from increased attention to the role of anxiety separately from depression...
  9. ncbi The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    Epilepsy Behav 5:337-42. 2004
    ..001). These data highlight the impact of comorbid depression on health care utilization by people with epilepsy...
  10. ncbi Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes
    Joyce Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    Value Health 6:566-73. 2003
    ..The objective of this study was to demonstrate the utility of continuous monitoring and enhancement of medication compliance during a long-term clinical trial, predictors of compliance, and relationships to drinking outcomes...
  11. ncbi Improved mood states with lamotrigine in patients with epilepsy
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    Epilepsy Behav 5:702-7. 2004
    ..The improvement likely was not a synergy but attributable only to LTG because it remained stable after withdrawal of the other AEDs...
  12. ncbi Quality of life in schizophrenia: a comparison of instruments. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia
    J A Cramer
    VA Connecticut Healthcare System, West Haven 06516 2770, USA
    Schizophr Bull 26:659-66. 2000
    ..Health-related quality of life in schizophrenia is a more heterogeneous concept than previously appreciated...
  13. ncbi Development of the Quality of Life in Epilepsy Inventory for Adolescents: the QOLIE-AD-48
    J A Cramer
    Yale University School of Medicine and VA Connecticut Healthcare System, Department of Psychiatry, New Haven 06516 2770, USA
    Epilepsia 40:1114-21. 1999
    ..We report the development of an instrument to assess health-related quality of life (HRQOL) in adolescents with epilepsy...
  14. ncbi Consequences of intermittent treatment for hypertension: the case for medication compliance and persistence
    J A Cramer
    Yale VA Medical Center, West Haven, CT 06516, USA
    Am J Manag Care 4:1563-8. 1998
    ..To review patient compliance with once-daily antihypertensive medications and the impact of partial compliance on healthcare outcomes...
  15. doi Non-interventional surveillance study of adverse events in patients with epilepsy
    J A Cramer
    Yale University, Epilepsy Therapy Project, Houston, TX 77027 9310, USA
    Acta Neurol Scand 124:13-21. 2011
    ..Compare adverse events (AEs) in patients with epilepsy taking different antiepileptic drugs (AEDs) using standardized physician-completed questionnaires...
  16. doi Adverse effects of antiepileptic drugs: a brief overview of important issues
    Joyce A Cramer
    Yale University School of Medicine, New Haven, CT, USA
    Expert Rev Neurother 10:885-91. 2010
    ..This article describes three categories of prevalent adverse effects (CNS, behavioral and general medical issues) comparing profiles of second- and third-generation AEDs...
  17. ncbi Detecting improvement in quality of life and symptomatology in schizophrenia
    J Cramer
    Northeast Program Evaluation Center, VA Connecticut Healthcare System, West Haven 06516 2770, USA
    Schizophr Bull 27:227-34. 2001
    ..88 and 0.92, respectively). Thus, modest changes in psychometric scales assessing symptoms and quality of life reflect clinically detectable improvement...
  18. ncbi Enhancing patient compliance in the elderly. Role of packaging aids and monitoring
    J A Cramer
    Health Services Research, Department of Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA
    Drugs Aging 12:7-15. 1998
    ..Some systems are also designed to notify patients within a day if doses were omitted. No system is optimal for all patients, but elderly patients deserve a comprehensive assessment of their needs to enhance medication compliance...
  19. ncbi Effect of levetiracetam on epilepsy-related quality of life. N132 Study Group
    J A Cramer
    Departments of Psychiatry and Neurology, Yale University School of Medicine, New Haven, Connecticut, USA
    Epilepsia 41:868-74. 2000
    ..To evaluate the short-term effect of levetiracetam (LEV; UCB L059) as add-on therapy on health-related quality of life in the treatment of refractory partial-onset seizures...
  20. ncbi Comparison between the QOLIE-31 and derived QOLIE-10 in a clinical trial of levetiracetam
    J A Cramer
    Department of Psychiatry, Yale University School of Medicine, Yale VA Medical Center, New Haven, CT 06516, USA
    Epilepsy Res 41:29-38. 2000
    ..to determine whether the QOLIE-10, an abbreviated quality of life questionnaire, provides results similar to the more detailed QOLIE-31 instrument when the ten items are derived from the QOLIE-31...
  21. ncbi New antiepileptic drugs: comparison of key clinical trials
    J A Cramer
    Yale University School of Medicine, New Haven, Connecticut, USA
    Epilepsia 40:590-600. 1999
    ..Drawbacks to use of these data also are demonstrated...
  22. ncbi The short-term impact of adjunctive tiagabine on health-related quality of life
    J Cramer
    Yale University School of Medicine, 950 Campbell Ave, West Haven, Connecticut 06516 2770, USA
    Epilepsia 42:70-5. 2001
    ..These exploratory analyses suggest a possible early positive effect of TGB on patient-perceived cognitive domains using the QOLIE-89. These findings are limited by the small sample size and could be related to reduction in seizures...
  23. ncbi Women with epilepsy: hormonal issues from menarche through menopause
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, West Haven, CT 06516, USA
    Epilepsy Behav 11:160-78. 2007
    ..This overview provides physicians with a background on the multiple issues relevant to women of all ages in the reproductive years, including those planning to conceive and those who are pregnant, and beyond the childbearing years...
  24. ncbi A systematic review of adherence with medications for diabetes
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
    Diabetes Care 27:1218-24. 2004
    ..The purpose of this study was to determine the extent to which patients omit doses of medications prescribed for diabetes...
  25. pmc The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review
    J A Cramer
    Yale University School of Medicine, West Haven, CT 06516 2770, USA
    Int J Clin Pract 62:76-87. 2008
    ....
  26. ncbi A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, 950 Campbell Avenue G7E, Room 7 127, West Haven, CT 06516 2770, USA
    Epilepsy Behav 4:124-32. 2003
    ..These data support the hypothesis that some feature related to epilepsy is the cause of many behavioral events rather than the addition of a specific antiepileptic drug...
  27. pmc Medicine partnerships
    J Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
    Heart 89:ii19-21; discussion ii35-7. 2003
    ..Simple steps that can be taken include helping patients to select "cues" to remind them to take their tablets, use of dose reminder boxes, and visual feedback of compliance data from electronic monitors...
  28. ncbi Principles of health-related quality of life: assessment in clinical trials
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06516 2770, USA
    Epilepsia 43:1084-95. 2002
  29. ncbi Brief report: a quality of life instrument for adolescents with growth disorders
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    J Adolesc 28:595-600. 2005
    ..Adolescents receiving growth hormone therapy differed significantly from adolescents with medical, surgical or psychiatric disorders. The VSP-AM shows reliability and validity for HRQOL measurement in adolescents with growth disorders...
  30. ncbi Development of a growth hormone injection questionnaire for adolescents
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, Yale VA Medical Center, Room 7 127 G7E, 950 Campbell Avenue, West Haven, CT 06516 2770, USA
    J Adolesc Health 34:27-9. 2004
    ..Summary scores did not differ significantly by cohort, age, gender, or diagnosis. Adolescents who were more comfortable with GH injections had higher health-related quality of life, functional capacity, and self-control...
  31. ncbi Compliance with inhaled insulin treatment using the AERx iDMS Insulin Diabetes Management System
    J A Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06516 2770, USA
    Diabetes Technol Ther 6:800-7. 2004
    ..This investigation was designed as a pilot trial to demonstrate the ability of patients to use the electronic device to deliver mealtime inhaled insulin doses and explore the impact on compliance...
  32. ncbi Quality of life improvement with conversion to lamotrigine monotherapy
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, 950 Campbell Avenue G7E, West Haven, CT 06516 2770, USA
    Epilepsy Behav 5:224-30. 2004
    ..This study demonstrates the value of reduction to monotherapy from the patients' and physicians' perspectives...
  33. ncbi Development of a new seizure severity questionnaire: initial reliability and validity testing
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, 950 Campbell Avenue G7E, New Haven, CT 06516 2770, USA
    Epilepsy Res 48:187-97. 2002
    ..This report describes the initial steps for development of a new scale to assess seizure severity as a treatment response...
  34. ncbi Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, 950 Campbell Avenue Room 7 127, West Haven, CT 06516, USA
    Epilepsy Behav 4:118-23. 2003
    ..Thus, gains in HRQOL were maintained during long-term LEV treatment, whether LEV was initiated early or late. Patient distress and importance of domains are useful data in determining how treatments impact on HRQOL...
  35. ncbi Persistence with bisphosphonate treatment for osteoporosis: finding the root of the problem
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06516 2770, USA
    Am J Med 119:S12-7. 2006
    ..It should be assumed that every patient receiving therapy for osteoporosis needs regular reinforcement of the importance of continuing therapy...
  36. ncbi The effect of dosing frequency on compliance and persistence with bisphosphonate therapy in postmenopausal women: a comparison of studies in the United States, the United Kingdom, and France
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, West Haven, Connecticut 06516 2770, USA
    Clin Ther 28:1686-94. 2006
    ..The aim of this study was to determine the effect of dose frequency on compliance and persistence with bisphosphonate therapy in postmenopausal women and to compare findings from 3 different health care systems...
  37. pmc Treatment persistence and compliance with medications for chronic obstructive pulmonary disease
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06516 2770, USA
    Can Respir J 14:25-9. 2007
    ..The present study assessed the patterns of persistence with the above mentioned inhaled medications...
  38. ncbi Results of a naturalistic study of treatment options: switching atypical antipsychotic drugs or augmenting with valproate
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, USA
    Clin Ther 26:905-14. 2004
    ..Combination therapy with atypical antipsychotic agents has not been well studied. Duration of persistence with a prescribed treatment regimen can be used to estimate overall treatment success...
  39. ncbi The influence of comorbid depression on quality of life for people with epilepsy
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, 950 Campbell Avenue G7E, New Haven, CT 06516 2770, USA
    Epilepsy Behav 4:515-21. 2003
    ..0001). Clinical depression is significantly associated with poorer HRQOL among people with all types of seizures...
  40. ncbi Patient satisfaction with an injection device for multiple sclerosis treatment
    J A Cramer
    Department of Psychiatry, Yale University, New Haven, CT 06516 2770, USA
    Acta Neurol Scand 113:156-62. 2006
    ....
  41. ncbi A systematic review of persistence and compliance with bisphosphonates for osteoporosis
    J A Cramer
    Department of Psychiatry, Yale University School of Medicine, 950 Campbell Avenue, 151D, West Haven, CT 06516 2770, USA
    Osteoporos Int 18:1023-31. 2007
    ..These studies confirm that women with osteoporosis have suboptimal persistence and compliance rates with bisphosphonate therapy...
  42. doi Medication compliance and persistence: terminology and definitions
    Joyce A Cramer
    Yale University School of Medicine, New Haven, CT, USA
    Value Health 11:44-7. 2008
    ..The aim of the study is to provide guidance regarding the meaning and use of the terms "compliance" and "persistence" as they relate to the study of medication use...
  43. ncbi The influence of insulin use on glycemic control: How well do adults follow prescriptions for insulin?
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
    Diabetes Care 28:78-83. 2005
    ..The purposes of this study were to determine the relationship between insulin self-management and glycemic control and to identify patient characteristics associated with better control...
  44. ncbi The influence of comorbid depression on seizure severity
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, 950 Campbell Avenue G7E, West Haven, CT 06516 2770, USA
    Epilepsia 44:1578-84. 2003
    ..To determine the relation between depressive symptoms and seizure severity among people with epilepsy...
  45. ncbi Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    Curr Med Res Opin 21:1453-60. 2005
    ..This study compared compliance and persistence with weekly and daily bisphosphonate regimens for postmenopausal osteoporosis...
  46. ncbi Does participation in psychosocial treatment augment the benefit of clozapine? Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia
    R Rosenheck
    Veterans Affairs Connecticut Healthcare System, West Haven 06516 2770, USA
    Arch Gen Psychiatry 55:618-25. 1998
    ..This study examines the role of participation in psychosocial treatment as a mediator of the clinical effectiveness of clozapine...
  47. ncbi Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia
    R Rosenheck
    VA Connecticut Healthcare System, West Haven 06516 2770, USA
    Am J Psychiatry 156:88-93. 1999
    ..This study compared the effect of clozapine and haloperidol on positive and negative symptoms of schizophrenia and in patients with high levels of negative symptoms or the deficit syndrome...
  48. ncbi Clinical and psychopharmacologic factors influencing family burden in refractory schizophrenia. The Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia
    R Rosenheck
    VA Connecticut Health Care System, West Haven, Conn 06516 2770, USA
    J Clin Psychiatry 61:671-6. 2000
    ..This study compares the effect of clozapine and haloperidol and identifies other factors related to family burden as experienced by relatives of patients with refractory schizophrenia (DSM-III-R)...
  49. ncbi Medication continuation and compliance: a comparison of patients treated with clozapine and haloperidol
    R Rosenheck
    VA Connecticut Healthcare System, West Haven, 06516 2770, USA
    J Clin Psychiatry 61:382-6. 2000
    ..This study compares medication continuation and regimen compliance with the atypical antipsychotic medication clozapine versus the conventional antipsychotic haloperidol...
  50. ncbi Cost-effectiveness of clozapine in patients with high and low levels of hospital use. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia
    R Rosenheck
    Veterans Affairs Connecticut Healthcare System, West Haven 06516 2770, USA
    Arch Gen Psychiatry 56:565-72. 1999
    ..This study examined the relationship between pretreatment hospital use and the cost-effectiveness of clozapine in the treatment of refractory schizophrenia...
  51. ncbi How long to wait for a response to clozapine: a comparison of time course of response to clozapine and conventional antipsychotic medication in refractory schizophrenia
    R Rosenheck
    VA s Northeast Evaluation Center, VA Connecticut Healthcare System, West Haven 06516 2770, USA
    Schizophr Bull 25:709-19. 1999
    ..04). Significant differential symptom response to clozapine occurred exclusively during the first 6 weeks of treatment...
  52. ncbi Interrater reliability levels of multiple clinical examiners in the evaluation of a schizophrenic patient: quality of life, level of functioning, and neuropsychological symptomatology
    D V Cicchetti
    Child Study Center, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    Clin Neuropsychol 13:157-70. 1999
    ..The authors develop just such an approach and apply it successfully to the evaluation of the functioning, quality of life, and neuropsychological symptomatology of a single schizophrenic patient...
  53. ncbi The role of comorbid psychiatric conditions in health status in epilepsy
    John E Zeber
    South Texas Veterans Health Care System HSR and D Verdict, San Antonio, TX 78229 4404, USA
    Epilepsy Behav 10:539-46. 2007
    ..Patients with epilepsy are uniquely at risk for high physical-psychiatric comorbidity profiles, with concomitant losses in perceived health status...
  54. ncbi The impact of epilepsy on health status among younger and older adults
    Mary Jo V Pugh
    Veterans Affairs HSR and D, South Texas Veterans Health Care System Verdict, San Antonio, Texas 78229 4404, USA
    Epilepsia 46:1820-7. 2005
    ..This study examines the impact of epilepsy on patients' subjective health status in a population that includes both younger and older adults...
  55. ncbi Validity and reliability of the Portuguese version of the quality of life in epilepsy inventory (QOLIE-31) for Brazil
    Tatiana Indelicato da Silva
    Department of Neurology, Escola Paulista de Medicina UNIFESP, Sao Paulo, Brazil
    Epilepsy Behav 10:234-41. 2007
    ..We report the cultural adaptation and psychometric properties of the Quality of Life in Epilepsy-31 Inventory (QOLIE-31) for the Portuguese language and Brazilian culture...
  56. ncbi Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures
    Christian Elger
    Department of Epileptology, University of Bonn, Bonn, Germany
    Epilepsia 48:497-504. 2007
    ..To explore the efficacy and safety of eslicarbazepine acetate (BIA 2-093), a new antiepileptic drug, as adjunctive therapy in adult patients with partial epilepsy...
  57. ncbi Electronic monitoring and counseling to improve medication adherence
    Marc I Rosen
    VA Connecticut Healthcare System, Department of Psychiatry 116A, 950 Campbell Avenue, West Haven, CT 06516, USA
    Behav Res Ther 42:409-22. 2004
    ..Data from nine patients who reviewed pill cap-generated data with their primary care providers suggested that both patients and providers found the discussion moderately helpful and not at all uncomfortable...
  58. ncbi Effects of illicit drug use on adherence to prescribed antiretroviral medication
    Marc I Rosen
    Department of Psychiatry, VA Connecticut Healthcare System, West Haven, CT 06516, USA
    Am J Addict 12:455-8. 2003
    ..Thus, in a subset of patients, the actions involved in procuring drugs and the acute effects of using them contribute to non-adherence on those specific drug use days, associated with substance abuse. (Am J Addict 2003;12:455-458)..
  59. ncbi Neuropsychological correlates of suboptimal adherence to metformin
    Marc I Rosen
    Department of Psychiatry, Yale University School of Medicine, VA Connecticut Healthcare System, West Haven, Connecticut, USA
    J Behav Med 26:349-60. 2003
    ..None of the neuropsychological variables were associated with glycosylated hemoglobin. These results suggest that cognitive abilities should be considered when counseling patients concerning their adherence...
  60. ncbi Reduced fracture rates observed only in patients with proper persistence and compliance with bisphosphonate therapies
    Stuart L Silverman
    Department of Medicine and Rheumatology, Cedars Sinai Medical Center UCLA, Beverly Hills, California 90211, USA
    South Med J 100:1214-8. 2007
    ..Measures to improve persistence and compliance with osteoporosis medications are needed if patients are to achieve the full clinical benefit of treatment...
  61. ncbi Persistence across weekly and monthly bisphosphonates: analysis of US retail pharmacy prescription refills
    Thomas W Weiss
    US Outcomes Research, Merck and Co, Inc, West Point, PA 19486 0004, USA
    Curr Med Res Opin 23:2193-203. 2007
    ..Determine whether monthly dosing of bisphosphonates has an impact on persistence relative to weekly dosing...
  62. ncbi Obtaining optimal compliance with drug therapy
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, Conn, USA
    Manag Care 12:9-11; discussion 23-5. 2003
  63. ncbi A checklist for medication compliance and persistence studies using retrospective databases
    Andrew M Peterson
    Department of Pharmacy Practice Pharmacy Administration, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, 600 South 43rd Street, Philadelphia, PA 19104, USA
    Value Health 10:3-12. 2007
    ..If followed, this checklist should improve the consistency and quality of C&P analyses, which in turn will help providers and payers understand the impact of C&P on health outcomes...
  64. doi Psychiatric disease burden profiles among veterans with epilepsy: the association with health services utilization
    Mary Jo V Pugh
    Veterans Evidence Based Research Dissemination Implementation Center, Health Services Research and Development Service, Department of Veterans Affairs, South Texas Veterans Healthcare System, San Antonio, TX 78229, USA
    Psychiatr Serv 59:925-8. 2008
    ..This brief report describes patterns of psychiatric comorbidities among patients with epilepsy and their relationship with health care utilization...
  65. ncbi Psychiatric safety of ketamine in psychopharmacology research
    Edward B Perry
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    Psychopharmacology (Berl) 192:253-60. 2007
    ..Therefore, it is timely to revisit the safety of subanesthetic doses of ketamine in experimental psychopharmacology studies...
  66. ncbi Cost analysis of divalproex sodium extended-release compared to valproic acid in the treatment of bipolar disorder
    Glen T Schumock
    Center for Pharmacoeconomic Research, University of Illinois at Chicago College of Pharmacy, Chicago, IL 60612, USA
    Curr Med Res Opin 23:1997-2004. 2007
    ..To analyze, from a payer perspective, the net pharmaceutical and medical costs of prescribing divalproex sodium extended-release (DVPX-ER) versus valproic acid (VPA) in patients with bipolar disorder...